Initiator Pharma A/S (STO: INIT)
Sweden
· Delayed Price · Currency is SEK
6.80
+0.15 (2.26%)
Nov 20, 2024, 3:48 PM CET
Initiator Pharma Balance Sheet
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 14.49 | 24.34 | 39.11 | 34.35 | 13.5 | 7.56 | Upgrade
|
Cash & Short-Term Investments | 14.49 | 24.34 | 39.11 | 34.35 | 13.5 | 7.56 | Upgrade
|
Cash Growth | -44.14% | -37.78% | 13.88% | 154.34% | 78.58% | -47.82% | Upgrade
|
Other Receivables | 5.72 | 5.43 | 7.21 | 4.13 | 2.03 | 2.97 | Upgrade
|
Receivables | 5.72 | 5.43 | 7.21 | 4.13 | 2.03 | 2.97 | Upgrade
|
Prepaid Expenses | - | - | 2.01 | 15.23 | - | - | Upgrade
|
Other Current Assets | - | - | - | - | 0.06 | 0.87 | Upgrade
|
Total Current Assets | 20.21 | 29.77 | 48.33 | 53.7 | 15.59 | 11.4 | Upgrade
|
Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
Other Intangible Assets | - | - | - | - | 0.01 | 0.03 | Upgrade
|
Other Long-Term Assets | 0.02 | 0.02 | 0.02 | - | - | -0 | Upgrade
|
Total Assets | 20.23 | 29.79 | 48.35 | 53.7 | 15.6 | 11.44 | Upgrade
|
Accounts Payable | 0.31 | 0.41 | 0.8 | 4.8 | 0.67 | 1.14 | Upgrade
|
Accrued Expenses | 0.87 | 2.53 | - | - | - | - | Upgrade
|
Other Current Liabilities | 0.13 | 0.25 | 0.94 | 0.62 | 0.53 | 0.39 | Upgrade
|
Total Current Liabilities | 1.31 | 3.19 | 1.75 | 5.42 | 1.19 | 1.53 | Upgrade
|
Long-Term Debt | - | 15.44 | 12.58 | 13.29 | - | - | Upgrade
|
Total Liabilities | 1.31 | 18.62 | 14.32 | 18.71 | 1.19 | 1.53 | Upgrade
|
Common Stock | 5.89 | 5.51 | 5.5 | 4.6 | 2.91 | 2.48 | Upgrade
|
Retained Earnings | 13.03 | 5.65 | 28.53 | 30.4 | 11.5 | 7.43 | Upgrade
|
Shareholders' Equity | 18.92 | 11.16 | 34.02 | 34.99 | 14.41 | 9.91 | Upgrade
|
Total Liabilities & Equity | 20.23 | 29.79 | 48.35 | 53.7 | 15.6 | 11.44 | Upgrade
|
Total Debt | - | 15.44 | 12.58 | 13.29 | - | - | Upgrade
|
Net Cash (Debt) | 14.49 | 8.9 | 26.54 | 21.06 | 13.5 | 7.56 | Upgrade
|
Net Cash Growth | 11.40% | -66.46% | 26.02% | 55.92% | 78.58% | -47.82% | Upgrade
|
Net Cash Per Share | 0.27 | 0.16 | 0.50 | 0.60 | 0.49 | 0.31 | Upgrade
|
Filing Date Shares Outstanding | 56.05 | 52.47 | 52.36 | 43.77 | 27.71 | 23.59 | Upgrade
|
Total Common Shares Outstanding | 56.05 | 52.47 | 52.36 | 43.77 | 27.71 | 23.59 | Upgrade
|
Working Capital | 18.9 | 26.58 | 46.58 | 48.28 | 14.4 | 9.87 | Upgrade
|
Book Value Per Share | 0.34 | 0.21 | 0.65 | 0.80 | 0.52 | 0.42 | Upgrade
|
Tangible Book Value | 18.92 | 11.16 | 34.02 | 34.99 | 14.4 | 9.87 | Upgrade
|
Tangible Book Value Per Share | 0.34 | 0.21 | 0.65 | 0.80 | 0.52 | 0.42 | Upgrade
|
Machinery | - | - | - | - | - | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.